The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis. 2021 to 2025" report has been added to ResearchAndMarkets.com's offering.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report
Covid-19 Awakens the sleeping giant of at-home diagnostics. Over the Counter and Direct to Consumer diagnostics are set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-Sampling technology key.
Genetic DTC testing led the way. Now Infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the DTC outlook for different syndromes. Find out where the action is and learn about the players.
Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
Market Trends
Factors Driving Growth- Privacy and Anonymity
- The Internet Effect
- Rapid Result
- The Wellness Movement
- The COVID-19 Impact
- Trust Factor
- Infectious Disease is Declining
- Wellness Hurts
- Economic Growth improves Living Standards
Companies Mentioned
- 1DropDiagnostics
- Abbott Diagnostics
- Ador Diagnostics
- Akonni Biosystems
- Alveo Technologies
- Applied BioCode
- Atomo Diagnostics
- Aus Diagnostics
- Becton, Dickinson and Company
- Binx Health
- Biocartis
- bioMerieux Diagnostics
- Bio-Rad Laboratories, Inc
- Bosch Healthcare Solutions GmbH
- Cepheid (now Danaher)
- Curetis N.V. / Curetis GmbH
- DBS Systems
- Diagenode Diagnostics
- Diasorin S.p.A
- Ellume
- Everywell
- Healthy.io
- Hologic
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Laboratory Corporation of America
- Letsgetchecked
- Lexagene
- Luminex Corp
- Mbio Diagnostics
- Mesa Biotech
- Mobidiag
- myLabBox
- Mylan
- Nanomix
- Orasure
- Oxford Nanopore Technologies
- Panagene
- Primerdesign
- Prominex
- Qiagen Gmbh
- Lucira Health
- Quantumdx
- Quest Diagnostics
- Quidel
- Roche Molecular Diagnostics
- Scanwell Health
- Seegene
- Seventh Sense Biosystems
- Siemens Healthineers
- T2 Biosystems
- TestCard
- Thermo Fisher Scientific Inc.
- Thriva
- XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/nkwlpz
View source version on businesswire.com: https://www.businesswire.com/news/home/20210225005849/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
